These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21680221)

  • 1. Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI.
    Gaujoux-Viala C; Mouterde G; Baillet A; Claudepierre P; Fautrel B; Le Loët X; Maillefert JF
    Joint Bone Spine; 2012 Mar; 79(2):149-55. PubMed ID: 21680221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt.
    Martins FM; da Silva JA; Santos MJ; Vieira-Sousa E; Duarte C; Santos H; Costa JA; Pimentel-Santos FM; Cunha I; Cunha Miranda L; Nóvoa T; Cruz M; Bernardes M; Araujo D; Pereira Silva JA; Silva JC; Branco JC; Gomes JA; Faustino A; Fonseca JE; Canhão H
    Rheumatology (Oxford); 2015 Feb; 54(2):286-91. PubMed ID: 25173347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
    Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
    Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
    Dhaon P; Das SK; Srivastava R; Dhakad U
    Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability and validity of CDAI and SDAI indices in comparison to DAS-28 index in Moroccan patients with rheumatoid arthritis.
    Slama IB; Allali F; Lakhdar T; El Kabbaj S; Medrare L; Ngeuleu A; Rkain H; Hajjaj-Hassouni N
    BMC Musculoskelet Disord; 2015 Sep; 16():268. PubMed ID: 26420567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.
    Santos IA; Donizeti Ribeiro de Oliveira R; Couto Luna Almeida S; Vargas-Santos AB; Balbino Chaves Amorim R; Monteiro Gomides AP; de Albuquerque CP; Barros Bertolo M; Brandão Resende Guimarães MF; da Costa Pinto MR; Gomes Resende G; Dalva Neubarth Giorgi R; de Carvalho Saciloto N; Radominski SC; Borghi FM; Rossi Bonfiglioli K; Carrico da Silva H; de Fatima L da Cunha Sauma M; Alves Pereira I; Werner de Castro GR; Viegas Brenol C; Machado Xavier R; Maria Henrique Mota L; Louzada-Junior P; da Rocha Castelar-Pinheiro G
    PLoS One; 2022; 17(9):e0273789. PubMed ID: 36174077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis.
    Ringold S; Chon Y; Singer NG
    Arthritis Rheum; 2009 Dec; 60(12):3776-83. PubMed ID: 19950286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.
    Klarenbeek NB; Koevoets R; van der Heijde DM; Gerards AH; Ten Wolde S; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Oct; 70(10):1815-21. PubMed ID: 21813548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the best target in a treat-to-target strategy in rheumatoid arthritis? Results from a systematic review and meta-regression analysis.
    Messelink MA; den Broeder AA; Marinelli FE; Michgels E; Verschueren P; Aletaha D; Tekstra J; Welsing PMJ
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37116986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
    Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
    Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).
    Salaffi F; Cimmino MA; Leardini G; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2009; 27(4):552-9. PubMed ID: 19772784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.
    Schoels M; Alasti F; Smolen JS; Aletaha D
    Arthritis Res Ther; 2017 Jul; 19(1):155. PubMed ID: 28676129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.
    Heegaard C; Dreyer L; Egsmose C; Madsen OR
    Clin Rheumatol; 2013 Oct; 32(10):1493-500. PubMed ID: 23754243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of indices of activity evaluation in rheumatoid arthritis.
    Hamdi W; Néji O; Ghannouchi MM; Kaffel D; Kchir MM
    Ann Phys Rehabil Med; 2011 Oct; 54(7):421-8. PubMed ID: 21996547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing remission in clinical practice.
    Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.
    Futó G; Somogyi A; Szekanecz Z
    Clin Rheumatol; 2014 May; 33(5):623-9. PubMed ID: 24599677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
    Kim SK; Park SH; Bae J; Son JT; Choe JY
    Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of disease activity indices in Korean patients with rheumatoid arthritis.
    Park SY; Lee H; Cho SK; Choi CB; Sung YK; Bae SC
    Rheumatol Int; 2012 Feb; 32(2):545-9. PubMed ID: 21305296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of composite disease activity indices for rheumatoid arthritis.
    Matsui T; Kuga Y; Nishino J; Kaneko A; Eto Y; Tohma S
    Mod Rheumatol; 2011 Apr; 21(2):134-43. PubMed ID: 20972600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.